We support communities disproportionately impacted by the HIV/AIDS epidemic by promoting comprehensive approaches and partnering with people and organizations making a difference. Through programs like the Gilead COMPASS Initiative®, we work with advocates and healthcare organizations to build awareness, reduce HIV-related stigma and promote holistic wellness of individuals through mental health services and trauma-informed care.
Did you know?
38% of the U.S. population lives in the South.
But the region accounts for more than half of new HIV
diagnoses in the country
each year.*
Through our regional-focused strategy, we support local organizations helping
meet the needs of people most impacted by the HIV/AIDS epidemic while committed to stemming the tide of
Coordinating Center: Emory University Rollins School of Public Health
Goal: Provide resources to help organizations more effectively scale and deliver support.
Coordinating Center: University of Houston Graduate College of Social
Work
Goal: Integrate focus on wellness, trauma, substance abuse and other mental health considerations to deliver
the best care.
Coordinating Center: Southern AIDS Coalition
Goal: Advocate for education, research and resources to combat the stigma, discrimination and health
disparities that people living with HIV can face.
By taking a comprehensive approach to R&D and patient care, we remain at the forefront of the latest innovations in HIV treatment.
Paving the Way Within the past decade, Gilead launched multiple antiviral therapies, including breakthrough treatments for HIV.
Stronger Than Ever 8 out of 10 people receiving treatment for HIV in the U.S. are taking a Gilead medication.
Looking to the Future We’re focused on developing additional therapeutic options to help address the diverse needs of HIV patients worldwide. Our ultimate goal is to prioritize innovative strategies in pursuit of a “functional cure” that would enable long-term viral suppression in the absence of antiretroviral therapy.
Our next chapter aims to build upon our achievements and continue challenging what we imagine is possible. We’re targeting the disease from every angle as we look forward to the day when the HIV/AIDS epidemic is a thing of the past.
Awarding more than $17.6 million in grants to support 30 organizations helping to address stigma, social isolation and better coordination of care for those aging with HIV.
In partnership with The Elton John AIDS Foundation, meaningfully addressing new HIV infections and AIDS-related deaths in Eastern Europe and Central Asia, where an estimated 1.7 million people are living with HIV.
Aiming to reduce new HIV infections by 40% among young women ages 10 to 24, helping them live determined, resilient, empowered and healthy lives.
Diana Brainard, SVP, HIV and Emerging Viruses at Gilead
The work is already underway. Read Gilead’s 2019 Year in Review to learn more.
Download the Report
Mobile
